ID HLAH_HUMAN Reviewed; 362 AA. AC P01893; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 05-OCT-2010, sequence version 3. DT 04-NOV-2026, entry version 179. DE RecName: Full=Putative HLA class I histocompatibility antigen, alpha chain H; DE AltName: Full=HLA-12.4; DE AltName: Full=HLA-AR; DE AltName: Full=MHC class I antigen H; DE Flags: Precursor; GN Name=HLA-H; Synonyms=HLAH; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=6461010; DOI=10.1073/pnas.79.3.893; RA Malissen M., Malissen B., Jordan B.R.; RT "Exon/intron organization and complete nucleotide sequence of an HLA RT gene."; RL Proc. Natl. Acad. Sci. U.S.A. 79:893-897(1982). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- INTERACTION: CC P01893; P11142: HSPA8; NbExp=2; IntAct=EBI-3197925, EBI-351896; CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass membrane CC protein {ECO:0000305}. CC -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}. CC -!- CAUTION: Could be the product of a pseudogene. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAA36218.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; J00191; AAA36218.1; ALT_INIT; Genomic_DNA. DR PIR; A02189; HLHU12. DR AlphaFoldDB; P01893; -. DR SMR; P01893; -. DR FunCoup; P01893; 289. DR IntAct; P01893; 15. DR NDEx; IQUERY-CP-HLA-H; 1 NDEx IQuery Curated Pathway. DR GlyCosmos; P01893; 1 site, No reported glycans. DR GlyGen; P01893; 2 sites, 1 O-linked glycan (1 site). DR iPTMnet; P01893; -. DR PhosphoSitePlus; P01893; -. DR SwissPalm; P01893; -. DR BioMuta; HGNC:4965; -. DR jPOST; P01893; -. DR MassIVE; P01893; -. DR ProteomicsDB; 51507; -. DR Pumba; P01893; -. DR AGR; HGNC:4965; -. DR GeneCards; HLA-H; -. DR HGNC; HGNC:4965; HLA-H. DR MIM; 142800; gene. DR InParanoid; P01893; -. DR PAN-GO; P01893; 9 GO annotations based on evolutionary models. DR PhylomeDB; P01893; -. DR PathwayCommons; P01893; -. DR Reactome; R-HSA-1236974; ER-Phagosome pathway. DR Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway. DR Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell. DR Reactome; R-HSA-6798695; Neutrophil degranulation. DR Reactome; R-HSA-877300; Interferon gamma signaling. DR Reactome; R-HSA-909733; Interferon alpha/beta signaling. DR Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses. DR Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC. DR SignaLink; P01893; -. DR ChiTaRS; HLA-H; human. DR Pharos; P01893; Tbio. DR PRO; PR:P01893; -. DR Proteomes; UP000005640; Unplaced. DR RNAct; P01893; protein. DR GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome. DR GO; GO:0009986; C:cell surface; IMP:UniProtKB. DR GO; GO:0031901; C:early endosome membrane; TAS:Reactome. DR GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome. DR GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central. DR GO; GO:0005576; C:extracellular region; IBA:GO_Central. DR GO; GO:0000139; C:Golgi membrane; TAS:Reactome. DR GO; GO:0098553; C:lumenal side of endoplasmic reticulum membrane; TAS:Reactome. DR GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0055038; C:recycling endosome membrane; TAS:Reactome. DR GO; GO:0030881; F:beta-2-microglobulin binding; IMP:UniProtKB. DR GO; GO:0042605; F:peptide antigen binding; IBA:GO_Central. DR GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central. DR GO; GO:0002486; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; IBA:GO_Central. DR GO; GO:0002476; P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; IBA:GO_Central. DR GO; GO:0006955; P:immune response; IBA:GO_Central. DR GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IBA:GO_Central. DR CDD; cd21026; IgC1_MHC_Ia_HLA-B; 1. DR FunFam; 2.60.40.10:FF:000014; H-2 class I histocompatibility antigen, alpha chain; 1. DR FunFam; 3.30.500.10:FF:000001; H-2 class I histocompatibility antigen, alpha chain; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 1. DR Gene3D; 3.30.500.10; MHC class I-like antigen recognition-like; 1. DR InterPro; IPR007110; Ig-like_dom. DR InterPro; IPR036179; Ig-like_dom_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003006; Ig/MHC_CS. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR050208; MHC_class-I_related. DR InterPro; IPR011161; MHC_I-like_Ag-recog. DR InterPro; IPR037055; MHC_I-like_Ag-recog_sf. DR InterPro; IPR011162; MHC_I/II-like_Ag-recog. DR InterPro; IPR001039; MHC_I_a_a1/a2. DR InterPro; IPR010579; MHC_I_a_C. DR PANTHER; PTHR16675:SF256; HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAIN H-RELATED; 1. DR PANTHER; PTHR16675; MHC CLASS I-RELATED; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR SMART; SM00407; IGc1; 1. DR SUPFAM; SSF48726; Immunoglobulin; 1. DR SUPFAM; SSF54452; MHC antigen-recognition domain; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. PE 5: Uncertain; KW Cell membrane; Disulfide bond; Glycoprotein; Immunity; Membrane; MHC I; KW Proteomics identification; Reference proteome; Signal; Transmembrane; KW Transmembrane helix. FT SIGNAL 1..24 FT /evidence="ECO:0000255" FT CHAIN 25..362 FT /note="Putative HLA class I histocompatibility antigen, FT alpha chain H" FT /id="PRO_0000018888" FT TOPO_DOM 25..308 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 309..332 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 333..362 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 209..297 FT /note="Ig-like C1-type" FT REGION 25..114 FT /note="Alpha-1" FT REGION 115..206 FT /note="Alpha-2" FT REGION 207..298 FT /note="Alpha-3" FT REGION 299..308 FT /note="Connecting peptide" FT REGION 337..362 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 342..356 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT CARBOHYD 110 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000250" FT DISULFID 227..283 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" SQ SEQUENCE 362 AA; 40892 MW; 8ADFD2388FEC4645 CRC64; MVLMAPRTLL LLLSGALALT QTWARSHSMR YFYTTMSRPG AGEPRFISVG YVDDTQFVRF DSDDASPREE PRAPWMEREG PKYWDRNTQI CKAQAQTERE NLRIALRYYN QSEGGSHTMQ VMYGCDVGPD GPFLRGYEQH AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAARRAEQR RVYLEGEFVE WLRRYLENGK ETLQRADPPK THMTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PEPLTLRWEP SSQPTVPIVG IVAGLVLLVA VVTGAVVAAV MWRKKSSDRK GGSYSQAASS NSAQGSDVSL TA //